Download PowerPoint File

Description:

Developed in Collaboration with and Endorsed by the American College of Clinical Pharmacy, American Society for Preventive Cardiology, National Lipid Association and Preventive Cardiovascular Nurses Association

Endorsed by Society for Cardiovascular Angiography and Interventions

See Also:
Guideline Hub | Chronic Coronary Disease

Date: July 20, 2023    

Clinical Topics: Anticoagulation Management, Cardiac Surgery, Cardiovascular Care Team, Diabetes and Cardiometabolic Disease, Dyslipidemia, Invasive Cardiovascular Angiography and Intervention, Prevention, Stable Ischemic Heart Disease, Atherosclerotic Disease (CAD/PAD), Cardiac Surgery and Arrhythmias, Cardiac Surgery and SIHD, Lipid Metabolism, Nonstatins, Novel Agents, Statins, Interventions and Coronary Artery Disease, Diet, Exercise, Chronic Angina

Keywords: Angiotensins, Colchicine, Renin, Myocardial Ischemia, Heart Diseases, Renal Insufficiency, Chronic, Anticoagulants, Disease Management, Risk Assessment, Coronary Disease, Lipids, Angina, Stable, Adrenergic beta-Antagonists, Angina Pectoris, Calcium Channel Blockers, Coronary Artery Bypass, Cardiac Rehabilitation, Chronic Disease, Coronary Artery Disease, Coronary Stenosis, Diabetes Mellitus, Type 2, Diet, Electronic Nicotine Delivery Systems, Exercise, Glucagon-Like Peptide-1 Receptor, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Life Style, Myocardial Infarction, Myocardial Ischemia, Myocardial Revascularization, Patient Care Team, PCSK9 protein, human, Platelet Aggregation, Proprotein Convertase 9, Risk Assessment, Secondary Prevention, Sodium-Glucose Transporter 2 Inhibitors, Stroke Volume, Subtilisins, Ventricular Function, Left, Vitamins